Abstract
Irreversible electroporation (IRE) is a newly developed non-thermal ablative therapy. During the IRE procedure, the permeability of the cell membrane is irreversibly changed by application of high-energy pulses across the tissue. This induces the breakdown of cell homeostasis, and thereby cell death. Here, we present an in vivo study to demonstrate IRE ablation of gastric tissue and characterize the changes that occur with time therein. No significant complications were observed in the test rats during the experiment. The electroporated tissues exhibited apoptosis at 10, 24 and 48 h after IRE ablation. The apoptosis peaked at 10 h after IRE and then declined, suggesting that the ablated tissue rapidly recovered owing to intense metabolic activity. In addition, the electroporated tissues exhibited morphological changes such as pyknosis and karyorrhexis, while histological analysis showed that the blood vessels were preserved. Interestingly, electroporation greatly affected the mucosa and muscularis propria, but not the submucosa and serosa. This study suggests that IRE could potentially be used as a minimally invasive treatment for early gastric cancer that does not exhibit lymph node metastasis or dysplasia.
Subject terms: Biotechnology, Biotechnology, Biotechnology, Biotechnology, Gastric cancer
Introduction
Electric pulses externally applied to cells induce instability in the lipid bilayer of the cell membrane, followed by formation of numerous nanoscale pores through the membrane, thereby increasing the trans-membrane permeability1,2. These electrically induced pores remain in the lipid bilayer for milliseconds to seconds and thereafter are closed once the electric pulse transmission is stopped3. Drugs, genes, enzymes, and antibodies can be injected into cells through these transient pores and this technique is called reversible electroporation4–6. However, if the energy of the pulses across the cell membrane is increased above a certain electrical field threshold, irreversible pores are formed in the membrane—this is then called irreversible electroporation (IRE)7. IRE leads to disruption of cell homeostasis and thereby cell death, without affecting non-cellular components such as the extracellular matrix, blood vessels, and nerves8,9.
Since Rubinsky et al.10–12 proposed that IRE could produce substantial tissue ablation and destroy undesirable tissues in the body, using mathematical and in vivo models, numerous papers have been published on the clinical applications of IRE. In particular, IRE has quickly pioneered a new type of cancer treatment, owing to it being an emerging, minimally invasive tissue ablation technology. Recent human pilot studies on malignancies have shown successful anticancer outcomes13,14. Moreover, the clinical use of IRE for ablation of breast, pancreatic, and brain tumours; blood vessels; and nerves has shown promising results in animal studies15–23.
Early gastric cancer is defined as carcinoma limited to the gastric mucosa or submucosa regardless of the lymph node status24. Endoscopic resection is the treatment of choice if the early gastric cancer and absence of lymph node metastasis is amenable to resection25. However, endoscopic resection has several drawbacks, including the need for a highly skilled endoscopist, lengthy procedure, and occurrence of serious adverse events such as bleeding and perforation (since the submucosa of the stomach is a thick layer of loose connective tissue that contains blood vessels, lymphatic vessels, and nerves26. In contrast, IRE is easy to perform, has a short procedure time, and seems to have a low risk of bleeding and perforation27–30. One case study showed that IRE was safe and tolerated by a gastric cancer patient with lymph node metastases29. Therefore, if effective ablation by IRE is demonstrated in the stomach tissue as well, the application of IRE for ablating stomach tumours would be an excellent complement to conventional treatment.
Recently, there have been some case reports and clinical studies on IRE in humans29,31–38. However, to the best of our knowledge, IRE has not yet been validated for its feasibility and potential use in the ablation of gastric tissue. Therefore, the aim of this study was to show feasibility for the clinical use of IRE in humans through validating the effects of IRE on rat stomach tissues and investigating the pathological changes that occur over time after IRE ablation.
Results
For applying irreversible electroporation in the rat stomach, the experiment was designed and set up as in Fig. 1. In order to accurately apply the electric pulses, the distribution of electric field around the electrodes with the external applied voltages of duty cycle 0.1% (pulse width 100 μs; pulse interval 100 ms) was initially calculated. The electric field distribution was dependent upon the external voltages. A strong field distribution was apparent at the centre of the electrode. The electric field was uniform between the two electrodes due to the length of electrodes (25 mm), but vaired at the edges of the electrodes (Fig. 2). We placed the stomach tissue in the region with uniform electric field (Fig. 1B(a)). In study 1, application of 2-kV/cm-50-pulse electroporation resulted in apoptosis, as shown in Fig. 3. As expected, the apoptotic ablation varied with time after IRE. Over time, the colour of the mucosa turned intensely brown and then progressively bleached, while the muscle layer was darkly coloured at 10 h after IRE and very light in colour at 24 and 48 h after IRE. Figure 3B shows the relationship between the apoptotic area and time lapse after IRE. The data were normalized due to subtle difference in distance between electrodes. The maximum apoptotic changes appeared at 10 h after IRE, being about 150-fold compared to that in the control (P < 0.05). These changes were significantly attenuated at 48 h through 24 h in comparison with those in the 10-h IRE samples (Fig. 3B). In order to further understand the histological changes occurring over time, H&E-stained samples of the stomach tissue taken immediately and 10, 24 and 48 h after IRE were analysed. On gross examination, no remarkable changes within the treated area of the rats exsanguinated immediately after IRE were observed. However, in the histological analysis of samples taken 10, 24 and 48 h after IRE, the IRE-treated areas presented with dark reddish mucosal defects with round depressions identical to the shape of the electrodes used to apply the pulse. Furthermore, a well-demarcated margin between the ablated zone and the surrounding non-ablated zone was noted macroscopically. The H&E-stained sample taken immediately after IRE, when compared with the 10-h sample, showed acute and severe damage to the tissue in the electroporated area (Fig. 4). Similarly, viable cells were not observed in the tissue samples examined 24 and 48 h after IRE. Instead, neutrophil infiltration was markedly increased throughout the treated area. However, the extracellular matrix and blood vessels, such as small arteries and arterioles within the ablated area retained their original structure (Fig. 4A).
It was evident that the gland structure was largely destroyed, with some haemorrhage within the electroporated area. The margin between the affected and unaffected regions was sharp and corresponded to the applied electrical field (Fig. 4). Notably, the number of dead cells was higher in the mucosa and muscularis propria than in the submucosa and serosa, likely because of their abundant cellular components.
In study 2, which involved IRE application at various amplitudes, all rats recovered fully after the experiment, without significant complications., All the tissue samples were collected at 10 h after IRE treatment, which was the time at which active apoptosis was observed, according to the results of study 1. Differences in the degree of changes in the stomach after IRE were seen among the groups. Figure 5A shows apoptotic changes in the tissues induced by the electrical energy (H&E stained samples). The 0 kV electrical energy did not induce apoptosis. Increasing apoptotic area was observed as the electrical energy was increased from 1 to 3 kV/cm. For IRE at 1 kV/cm, the only remarkable change in the muscularis propria was mild vacuolar formation (Fig. 5A(b)). The submucosa, serosa, and nonablated sites did not show any definite changes. The mucosal defect also went deeper and became more prominent as the electrical energy increased, resulting in cells within the electroporated area becoming uniformly and completely nonviable and showing an extensive degree of pyknosis and karyorrhexis (Fig. 5A(c,d)). Positive TUNEL assay results were observed in the ablated zone, indicating apoptotic cell death (Fig. 5B). As the electric field strength increased, the extent of mucosal damage increased, and wall thinning was observed at 3 kV/cm. The thickness of the mucosa was less at 3 kV/cm than at 1 kV/cm, owing to the shedding of dead cells.
Discussion
The present study demonstrated that IRE could effectively ablate the stomach tissue through the induction of apoptosis. Moreover, it was revealed that the cellular components were completely ablated by IRE, whereas the extracellular matrix and blood vessels preserved their structural integrity. In this study, cell death due to IRE was uniform and complete within the electroporated area, and it was confined to the area where the electric field was applied. Well-demarcated tissue ablation between the ablated and non-ablated areas at cell-scale resolution is one of the characteristics of IRE, and has been validated in previous studies conducted on other organs39,40. In our study, we corroborated that the ability of IRE to precisely ablate tissue as intended holds true for stomach tissue.
The histological changes—cell death, pyknosis, karyorrhexis, destruction of gland structure, and vascular congestion—were observed only in the ablated areas. Additionally, positive TUNEL staining, indicating apoptosis, was restricted to the ablated areas and was absent in the adjacent regions. These results indicate the possibility that IRE is able to selectively destroy an undesirable tissue without collateral damage to the surrounding normal tissue.
In addition, IRE can effectively ablate the target tissue in micro- to milliseconds of treatment time, as compared to the conventional endoscopic resection that requires at least 30 min, and possibly even hours26. Once the electrodes are accurately positioned, IRE treatment is completed within a few seconds. Given the shorter procedure time and precise tissue targeting, IRE could be a potential treatment alternative to endoscopic resection for early gastric cancer or dysplasia, with less complications and better outcomes.
Apoptosis is a common underlying mechanism by which cell death occurs after IRE.41. The apoptosis may not be visible by histological and pathological methods as time passes42. This may be related to the apoptotic cell clearance mechanism43. The clearance is related to the phagocyte-apoptotic cell interactions that are required for highly efficient removal of dead cells. The engulfment of phagocyte is associated with activation of Rac43. When Rac is up-regulated, DNA degradation follows. The DNA fragmentation can be assayed by the TUNEL assay, which is one of the most widely used methods for this purpose44,45. As seen in Fig. 3, cells within the electroporated area at 10, 24 and 48 h after IRE stained positively with a dark brown colour in the TUNEL assay. In addition, DNA degradation as revealed by the TUNEL assay peaked at 10 h after IRE, and then declined slightly at 24 h and rapidly at 48 h after IRE46. This suggests that the ablated tissue may rapidly recover within these times due to vigorous metabolic activity from the blood circulation42,43,46. Here, in Fig. 3A, what seems to be different in distance between electrodes was from which the electrodes were split more or less than 10 mm of distance, when inserting electrodes into the body of stomach. In spite of that, the apoptotic area was well normalized each other in calculation. The apoptotic region may be correlated with the density of the applied electrical energy. From this correlation, we were able to deduce the minimum strength of electrical energy required to induce apoptosis. We calculated the density for the 2 kV electrical energy that was simulated in Fig. 2B, based on the aforementioned Eq. 3. Figure 6B illustrates the areas of ablation contour for 2 kV electrical energy. In the absence of cross-sectional sliced images, it is difficult to calculate the exact threshold of critical energy density. However, we can postulate it to be around 0.8 kV/cm42,46. Although the submucosa and serosa were within the applied electrical field, they were not affected. Nevertheless, this study was limited as it evaluated the pathological changes only at 10, 24 and 48 h after IRE. Follow-up studies for long-term outcome are needed to accurately assess the changes after IRE application.
Apoptosis causes morphological changes in the cell. The morphological changes include an irreversible condensation of chromatin material in the nucleus of the cell undergoing apoptosis. A highly extensive degree of pyknosis and karyorrhexis was seen throughout the electroporated area (Fig. 4A) in samples at 10, 24 and 48 h after IRE treatment, but not in samples immediately after pulse treatment. IRE preserves tissue constituents, especially major tissue vasculature since it exclusively targets the cell membrane, and hence only the cellular components47. As seen in Fig. 3A, histological analysis showed that the blood vessels were preserved, the extracellular matrix was intact, and only the cells were ruptured and non-viable. Such observations were seen largely within the mucosa and muscularis propria, but not in the submucosa and serosa. (Figs 4B and 6A). According to literature27, this is because the gastric submucosa and serosa do not have enough cellular components; however, they are abundant in connective tissues such as collagen and elastin. IRE also caused these things within tissues that were subjected to the energy domain as in Fig. 5.
Interestingly, intact tissue structural components and blood vessels seem to provide a platform for rapid tissue regeneration and contribute to minimal scarring of the treated tissue after IRE48, as documented in earlier reports on the liver, prostate, and kidney49–51. Rapid tissue recovery after IRE ablation has been reported for the gastrointestinal tract27,52. In this study, tissue repair was already evident 3 days after IRE, and the intestinal layers and villi were regenerated within 7 days. The study suggested that the ability of IRE to preserve the extracellular matrix, blood vessels, and nerves aids in the rapid recovery of the small intestine after IRE-induced tissue damage52. In fact, delayed tissue healing after treatment seems to be problematic in clinical applications, because it impedes secondary treatment53. Rapid tissue recovery after ablation is therefore certainly another advantage of IRE.
This is the first report to validate the effectiveness of IRE on the stomach, however, there are a few limitations to this study that must be acknowledged. This study involved transmural delivery of the electric pulse so as to identify the effect of IRE on the complete gastric tissue. However, this does not reflect real clinical settings, wherein the IRE would be applied through the mucosal or intramucosal route in the gastrointestinal tract wherein the electrodes would be inserted through a channel of an endoscope to deliver the electric pulses. Moreover, this study was performed in normal rat gastric tissue. Since electrical properties, such as impedance, conductivity, and permittivity, differ between cancerous and healthy tissues, the effect of IRE ablation on a normal tissue would be different from the effect on gastric cancerous tissue or dysplastic tissue. In addition, the thermal effect of the pulse treatment was not evaluated. The long-term effect on recovery and regeneration of gastric tissue after IRE also needs to be studied.
Conclusion
No complications were observed in any animals during the experiments.The apoptotic changes in the gastric tissue as observed through histological techniques and TUNEL assay, seemed to appear at 10 h after IRE and were then attenuated at 24 and 48 h after IRE. The corresponding tissue in an ablated area preserved the extracellular matrix and blood vessels as seen by H&E staining, although neutrophil infiltration was markedly increased throughout the treated area. With application of enhanced electric field strength, the apoptotic area was significantly increased. The extensive degree of pyknosis and karyorrhexis within the IRE-mediated ablated tissue was corroborated at the level of cells. The results of this study could be used to develop strategies for treating gastric cancer or dysplasia through endoscopy combined with IRE.
Materials and Methods
Animal preparation
Twenty-seven, six-week-old, female Sprague-Dawley rats (300–400 g) were purchased from Orient. Co. Ltd. (Korea). The animals were acclimatized to the environment by housing them at 22 ± 3 °C in light-controlled conditions (12-h light and dark cycle) for one week (Fig. 1A). The animals were then fasted, but were provided water, for 24 h before the initiation of the experiments. All experimental procedures and animal care were performed in accordance with the protocols approved by the Institutional Animal Care & Use Committee, Korea University (IACUC no. KOREA-2016–0062)
IRE protocol and experimental set-up
To perform in vivo IRE ablation in the rat stomach, the rats are anaesthetized with isofluorane inhalation after medication with muscle relaxants. After skin preparation by shaving and decontamination with an iodine surgical scrub and 70% ethanol, the abdominal wall was dissected to visualize the stomach. Thereafter, two needle electrodes (syringe needle 26 gauge (diameter: 0.404 mm, length: 25 mm) made with stainless steel) with 10-mm separation were inserted into the stomach (Fig. 1B(a)), which has lower conductivity. The two needles were then connected to an electroporator (ECM 830 Electroporator; BTX Genetronics, San Diego, CA), which provides a square wave pulse (maximum voltage, 3,000 V; pulse duration of 10 μsec to 999 ms) via a cable (provided by BTX Genetronics) (Fig. 1B(c)). Here, the applied rectangular direct current pulses had a pulse width of 100 μs and a pulse interval of 100 ms, gained from using an oscilloscope (Protek 3120 with PCP-5000 current probe, Korea) (Fig. 1B(c)). When we apply, the 5-pulse was delivered each at one time and 10 groups in manual to totally be 50 pulses in order to avoid the pulse-resulted thermal effect. However, if an arc was formed between the two electrodes during IRE, we discarded the sample and used a fresh one to repeat the procedure. Th arc occurred one time at applying 3 kV/cm. Following the electroporation, the abdominal incision was closed using surgical staplers (Fig. 1B(b)). The mice were fasted until sacrifice, for collection of tissue for further study. Two different electrical pulses were applied according to the methods of “study 1” and “study 2” (Table 1).
Table 1.
E.field (kV/cm) | Pulse number | Groups | Pulse width/interval | |||||
---|---|---|---|---|---|---|---|---|
Study 1 | 2 | 50 | Con | 0 h | 10 h | 24 h | 48 h | 100 μs/100 ms |
n = 3 | ||||||||
Study 2 | 1 ~ 3 | 50 | Con | 1 kV/cm | 2 kV/cm | 3 kV/cm | ||
n = 3 |
Study 1. Comparison of changes over time in the stomach after IRE
In order to investigate the apoptotic changes taking place over time post irreversible electroporation, the constant 2-kV/cm-50-pulse with pulse width of 100 µs was applied to fifteen rats. These were divided into five groups: non-ablated control group (n = 3), 0-h group (n = 3), 10-h group (n = 3), 24-h group (n = 3), and 48-h group (n = 3). Each of them was sacrificed at their set times after irreversible electroporation.
Study 2. Comparison according to application of various amplitudes for IRE generation in the stomach
Twelve rats were divided into four groups: non-ablated control group (n = 3), 1 kV/cm group (n = 3), 2 kV/cm group (n = 3), and 3 kV/cm group (n = 3). Fifty direct current pulses of 100 µs width were applied with electric field strengths of 1, 2 and 3 kV/cm to investigate the IRE effectiveness of the applied electric field strengths. All rats were sacrificed at 10 h after IRE. These electrical parameters are known to be sufficient to induce IRE in gastric tissue54.
Tissue collection and histological analysis
After IRE treatment, the stomachs were excised and fixed in 10% neutral buffered formalin for at least 24 h. We trimmed the tissues of the IRE-ablated and non-ablated areas. The non-ablated tissues were used as the controls. The tissues were embedded in paraffin and sectioned into 1-mm-thick slices, and then stained with haematoxylin and eosin (H&E) for histomorphological analysis. To verify apoptotic cell death caused by IRE ablation, terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assays were conducted using an In Situ Cell Death Detection, POD kit (Roche, Germany), This method detects DNA fragmentation resulting from apoptotic signalling cascades by labelling the terminal end of nucleic acids. The slides for the TUNEL assay were imaged with an image acquisition system (Olympus BX-51 with digital imaging system (Image-Pro plus 4.5)), and the area coloured brown by TUNEL staining was then analysed via MATLAB (R2018b, 9.5.0.944444, The MathWorks, Inc., Natick, Massachusetts, USA) to quantify the degree of apoptosis in the region of interest.
Analytical modelling of the ablation area
The applied electric field strength distribution is an important parameter to determine the tissue ablation by IRE. The steady state electric field distribution is obtained by solving the Laplace equation,
1 |
where ∅ is the electric potential, assuming that the electrodes length is larger than the distance between the electrodes and the effect of tissue surface is neglected42. The electric field is calculated as the gradient of electric field potential.
2 |
The boundary condition of tissue was defined as ∅ = V0 or 0. The remaining boundaries were considered to be electrically insulating . We calculated the electric field using Epo codeTM (The Standard Co. Ltd., Korea) developed by open source application OpenFOAM for the above conditions.
The electric field is related to electric energy density and thus gives us information about the threshold strength of the electric field required to induce a apoptosis.The applied electric energy density is expressed as42:
3 |
Where , Δt is the time duration of the electric field application, n is the number of the pulses. The curve of points where the electric energy density is the critical value wc and is the ablated area’s boundary.
Statistical analysis
Data were analysed using Microsoft Excel. Means and standard deviations were calculated. An unpaired two-sided student’s t test was applied to all data. Results were considered to be statistically significant when P < 0.05.
Acknowledgements
This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIT) (No. 2017R1C1B2006425 and 2018R1C1B6006044) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3477).
Author Contributions
H.S.C. and H.J.C. conceived and designed the experiments. H.S.C. and H.B.K. designed the experimental methodologies. J.M.L., H.B.K. and H.S.C. ran experiments and collected data. E.S.K., B.K., Y.S.S., Y.T.J. and S.H.U. analysed results. H.B.K. drew Figure 1 B(b) and simulated the applied electric field distribution and the applied electric energy density. H.J.C., H.S.L. and C.D.K. supervised the study. J.M.L. wrote the draft and H.S.C. revised the manuscript. All authors contributed to writing, editing, and review of the manuscript.
Competing Interests
The authors declare no competing interests.
Footnotes
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Jae Min Lee and Hong Bae Kim contributed equally.
Change history
11/27/2019
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
References
- 1.Weaver JC. Electroporation theory. Concepts and mechanisms. Methods Mol. Biol. 1995;55:3–28. doi: 10.1385/0-89603-328-7:3. [DOI] [PubMed] [Google Scholar]
- 2.Tieleman DP, Leontiadou H, Mark AE, Marrink SJ. Simulation of pore formation in lipid bilayers by mechanical stress and electric fields. J. Am. Chem. Soc. 2003;125:6382–6383. doi: 10.1021/ja029504i. [DOI] [PubMed] [Google Scholar]
- 3.Abiror IG, et al. 246-electric breakdown of bilayer lipid membranes I. The main experimental facts and their qualitative discussion. Bioelectrochem. Bioenerg. 1979;6:37–52. doi: 10.1016/0302-4598(79)85005-9. [DOI] [Google Scholar]
- 4.Heller R, Gilbert R, Jaroszeski MJ. Clinical applications of electrochemotherapy. Adv. Drug Deliv. Rev. 1999;35:119–129. doi: 10.1016/S0169-409X(98)00067-2. [DOI] [PubMed] [Google Scholar]
- 5.Mir LM, Moller PH, Andre F, Gehl J. Electric pulse-mediated gene delivery to various animal tissues. Adv. Genet. 2005;54:83–114. doi: 10.1016/S0065-2660(05)54005-7. [DOI] [PubMed] [Google Scholar]
- 6.Kranjc, S., Cemazar, M., Grosel, A., Sentjurc, M. & Sersa, G. Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice. BMC Cancer5 (2005). [DOI] [PMC free article] [PubMed]
- 7.Lee RC. Cell injury by electric forces. Ann. Ny. Acad. Sci. 2005;1066:85–91. doi: 10.1196/annals.1363.007. [DOI] [PubMed] [Google Scholar]
- 8.Rubinsky B, Onik B, Mikus P. Irreversible electroporation: a new ablation modality – clinical implications. Technol. Cancer Res. Treat. 2007;6:37–48. doi: 10.1177/153303460700600106. [DOI] [PubMed] [Google Scholar]
- 9.Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC., II Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J. Surg. Oncol. 2013;107:544–549. doi: 10.1002/jso.23280. [DOI] [PubMed] [Google Scholar]
- 10.Rubinsky B. Irreversible electroporation in medicine. Technol. Cancer Res. Treat. 2007;6:255–260. doi: 10.1177/153303460700600401. [DOI] [PubMed] [Google Scholar]
- 11.Davalos RV, Rubinsky B, Mir LM. Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry. 2003;61:99–107. doi: 10.1016/j.bioelechem.2003.07.001. [DOI] [PubMed] [Google Scholar]
- 12.Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 2005;33:223–231. doi: 10.1007/s10439-005-8981-8. [DOI] [PubMed] [Google Scholar]
- 13.Thomson KR, et al. Investigation of the safety of irreversible electroporation in humans. J. Vasc. Interv. Radiol. 2011;22:611–621. doi: 10.1016/j.jvir.2010.12.014. [DOI] [PubMed] [Google Scholar]
- 14.Pech M, et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc. Intervent. Radiol. 2011;34:132–138. doi: 10.1007/s00270-010-9964-1. [DOI] [PubMed] [Google Scholar]
- 15.Schoellnast H, et al. Acute and subacute effects of irreversible electroporation on nerves: experimental study in a pig model. Radiology. 2011;260:421–427. doi: 10.1148/radiol.11103505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Luo X, et al. The effects of irreversible electroporation on the colon in a porcine model. PLoS One. 2016;11:e0167275. doi: 10.1371/journal.pone.0167275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Garcia PA, Rossmeisl JH, Jr., Davalos RV. Electrical conductivity changes during irreversible electroporation treatment of brain cancer. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2011;2011:739–742. doi: 10.1109/IEMBS.2011.6090168. [DOI] [PubMed] [Google Scholar]
- 18.Sanchez-Velazquez, P. et al. Irreversible electroporation of the liver: is there a safe limit to the ablation volume? Sci. Rep-Uk6 (2016). [DOI] [PMC free article] [PubMed]
- 19.Rombouts SJ, et al. Irreversible electroporation of the pancreas using parallel plate electrodes in a porcine model: A feasibility study. Plos One. 2017;12:e0169396. doi: 10.1371/journal.pone.0169396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: Definitive local therapy without systemic effects. J. Surg. Oncol. 2011;104:22–28. doi: 10.1002/jso.21899. [DOI] [PubMed] [Google Scholar]
- 21.Sanchez-Velazquez P, et al. Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis. Sci. Rep. 2017;7:44821. doi: 10.1038/srep44821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Neal RE, 2nd, et al. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res. Treat. 2010;123:295–301. doi: 10.1007/s10549-010-0803-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Maor E, Ivorra A, Mitchell JJ, Rubinsky B. Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J. Vasc. Interv. Radiol. 2010;21:1708–1715. doi: 10.1016/j.jvir.2010.06.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Murakami T. Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann. Monogr. Cancer Res. 1971;11:53–55. [Google Scholar]
- 25.Ono H, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig. Endosc. 2016;28:3–15. doi: 10.1111/den.12518. [DOI] [PubMed] [Google Scholar]
- 26.Pagitz M, Koch M, Hausmann J, Albert J. High-quality endoscopic mucosal resection – the process explained. Dtsch. Med. Wochenschr. 2018;143:1032–1038. doi: 10.1055/s-0043-124450. [DOI] [PubMed] [Google Scholar]
- 27.Li JN, et al. Evaluation of the safety of irreversible electroporation on the stomach wall using a pig model. Exp. Ther. Med. 2017;14:696–702. doi: 10.3892/etm.2017.4559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ohta H, Izumi S, Yoshimoto M. A more acceptable endoluminal implantation for remotely monitoring ingestible sensors anchored to the stomach wall. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2015;2015:4089–4092. doi: 10.1109/EMBC.2015.7319293. [DOI] [PubMed] [Google Scholar]
- 29.Klein N, Zapf S, Gunther E, Stehling M. Treatment of lymph node metastases from gastric cancer with a combination of irreversible electroporation and electrochemotherapy: A case report. Clin. Case Rep. 2017;5:1389–1394. doi: 10.1002/ccr3.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Min, G. et al. Development of new endoscopic irreversible electroporation ablation device: Animal experimental study. J. Clin. Oncol. 36 (2018).
- 31.Zhang, W. L. et al. Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study. Plos One12 (2017). [DOI] [PMC free article] [PubMed]
- 32.Martinii RCG., II Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation. J. Surg. Oncol. 2017;116:35–45. doi: 10.1002/jso.24640. [DOI] [PubMed] [Google Scholar]
- 33.Zeng JY, et al. The safety and efficacy of irreversible electroporation for large hepatocellular carcinoma. Technol. Cancer Res. Treat. 2017;16:120–124. doi: 10.1177/1533034616676445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Scheltema MJ, et al. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer. Bju. Int. 2017;120:51–58. doi: 10.1111/bju.13991. [DOI] [PubMed] [Google Scholar]
- 35.Scheltema, M. J. et al. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer16 (2016). [DOI] [PMC free article] [PubMed]
- 36.Vogel JA, et al. Induction chemotherapy followed by resection or irreversible electroporation in locally advanced pancreatic cancer (IMPALA): A prospective cohort study. Ann. Surg. Oncol. 2017;24:2734–2743. doi: 10.1245/s10434-017-5900-9. [DOI] [PubMed] [Google Scholar]
- 37.Stillstrom D, et al. A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas. Surg. Endosc. 2017;31:1982–1985. doi: 10.1007/s00464-016-5173-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Mansson C, Brahmstaedt R, Nilsson A, Nygren P, Karlson BM. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. Eur. J. Surg. Onc. 2016;42:1401–1406. doi: 10.1016/j.ejso.2016.01.024. [DOI] [PubMed] [Google Scholar]
- 39.Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol. Cancer Res. Treat. 2007;6:307–312. doi: 10.1177/153303460700600407. [DOI] [PubMed] [Google Scholar]
- 40.Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning. Technol. Cancer Res. Treat. 2007;6:275–286. doi: 10.1177/153303460700600403. [DOI] [PubMed] [Google Scholar]
- 41.Guo Y, et al. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res. 2010;15:1555–63. doi: 10.1158/0008-5472.CAN-09-3067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Sung CK, et al. Histological and mathematical analysis of the irreversibly electroporated liver tissue. Technol. Cancer Res. Treat. 2017;16:488–496. doi: 10.1177/1533034616640642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Elliott MR, Ravichandran KS. The dynamics of apoptotic cell clearance. Dev. Cell. 2016;25:147–60. doi: 10.1016/j.devcel.2016.06.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Mao YH, et al. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Oncol. Rep. 2016;36:49–56. doi: 10.3892/or.2016.4820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992;119:493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Choi YS, et al. Preclinical analysis of irreversible electroporation on rat liver tissues using a microfabricated electroporator. Tissue Eng. Part C-Methods. 2010;16:1245–1253. doi: 10.1089/ten.tec.2009.0803. [DOI] [PubMed] [Google Scholar]
- 47.Lee EW, Thai S, Kee ST. Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver. 2010;4(Suppl 1):S99–S104. doi: 10.5009/gnl.2010.4.S1.S99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Filipowska J, Tomaszewski KA, Niedźwiedzki Ł, Walocha JA, Niedźwiedzki T. The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis. 2017;20:291–302. doi: 10.1007/s10456-017-9541-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality–clinical implications. Technol. Cancer Res. Treat. 2007;6:37–48. doi: 10.1177/153303460700600106. [DOI] [PubMed] [Google Scholar]
- 50.Onik G, Mikus P, Rubinsky B. Irreversible electroporation: Implications for prostate ablation. Technol. Cancer Res. Treat. 2007;6:295–300. doi: 10.1177/153303460700600405. [DOI] [PubMed] [Google Scholar]
- 51.Deodhar A, et al. Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology. 2011;77:754–760. doi: 10.1016/j.urology.2010.08.036. [DOI] [PubMed] [Google Scholar]
- 52.Phillips MA, Narayan R, Padath T, Rubinsky B. Irreversible electroporation on the small intestine. Brit. J. Cancer. 2012;106:490–495. doi: 10.1038/bjc.2011.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Liu J, et al. Comparing the hydrosurgery system to conventional debridement techniques for the treatment of delayed healing wounds: a prospective, randomised clinical trial to investigate clinical efficacy and cost-effectiveness. Int. Wound J. 2015;12:456–61. doi: 10.1111/iwj.12137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Nina K. Treatment of lymph node metastases from gastric cancer with a combination of irreversible electroporation and electrochemotherapy: a case report. Clin. Case. Rep. 2017;5:1389–1394. doi: 10.1002/ccr3.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]